Literature DB >> 24000044

Unbound fraction of vancomycin in intensive care unit patients.

Martin G Kees1, Sebastian G Wicha, Astrid Seefeld, Frieder Kees, Charlotte Kloft.   

Abstract

Published data on the unbound fraction of vancomycin in patient samples exhibit high variability. In the present study, a robust ultrafiltration method was developed and applied to 102 clinical samples from 22 intensive care unit patients who were treated with continuous infusion of vancomycin. A validated HPLC method was used for determination of total and unbound concentrations. The mean unbound fraction was 67.2% (standard deviation 7.5%, range 47.2-92.1%) and independent of total concentration of vancomycin or of albumin. The unbound fraction was significantly correlated (r = +0.67, P = .0009) with the renally filtered fraction (drug clearance/creatinine clearance), providing functional evidence for the validity of the measurements. Ultrafiltration proved to be susceptible to variations in the experimental conditions such as pH, temperature and centrifugal force. The measured unbound fraction increased from 60% at pH 6 to 100% at pH 9, from 57% at 4°C to 80% at 37°C, and was 76% at 1,000 g compared with 45% at 10,000 g. Lack of standardization may therefore partly explain the variable results reported in the literature.
© 2013, The American College of Clinical Pharmacology.

Entities:  

Keywords:  HPLC; antibiotics; hypoalbuminemia; protein binding; ultrafiltration

Mesh:

Substances:

Year:  2013        PMID: 24000044     DOI: 10.1002/jcph.175

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  14 in total

1.  Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.

Authors:  Khaled Abduljalil; Xian Pan; Amita Pansari; Masoud Jamei; Trevor N Johnson
Journal:  Clin Pharmacokinet       Date:  2020-04       Impact factor: 6.447

2.  Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis.

Authors:  Olivier Mangin; Saïk Urien; Jean-Luc Mainardi; Jean-Yves Fagon; Christophe Faisy
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

3.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

4.  Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patients.

Authors:  L H M te Brake; R Ruslami; H Later-Nijland; F Mooren; M Teulen; L Apriani; J B Koenderink; F G Russel; D M Burger; B Alisjahbana; F Wieringa; R van Crevel; R E Aarnoutse
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

5.  Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.

Authors:  Michael Schleibinger; Cathérine L Steinbach; Christoph Töpper; Alexander Kratzer; Uwe Liebchen; Frieder Kees; Bernd Salzberger; Martin G Kees
Journal:  Br J Clin Pharmacol       Date:  2015-06-11       Impact factor: 4.335

6.  Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios.

Authors:  Hannah Yejin Kim; Kenneth C Byashalira; Scott K Heysell; Anne-Grete Märtson; Stellah G Mpagama; Prakruti Rao; Marieke G G Sturkenboom; Jan-Willem C Alffenaar
Journal:  Ther Drug Monit       Date:  2022-02-01       Impact factor: 3.118

7.  Factors impacting unbound vancomycin concentrations in neonates and young infants.

Authors:  Anne Smits; Steven Pauwels; Matthijs Oyaert; Nele Peersman; Isabel Spriet; Veroniek Saegeman; Karel Allegaert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-16       Impact factor: 3.267

8.  Factors impacting unbound vancomycin concentrations in different patient populations.

Authors:  Matthijs Oyaert; Isabel Spriet; Karel Allegaert; Anne Smits; Kim Vanstraelen; Nele Peersman; Joost Wauters; Jan Verhaegen; Pieter Vermeersch; Steven Pauwels
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

9.  Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.

Authors:  Olivier Deltombe; Wim Van Biesen; Griet Glorieux; Ziad Massy; Annemieke Dhondt; Sunny Eloot
Journal:  Toxins (Basel)       Date:  2015-09-28       Impact factor: 4.546

10.  Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role.

Authors:  Xiao Li; Wen Xu; Ran Li; Qie Guo; Xiangpeng Li; Jialin Sun; Shuhong Sun; Jing Li
Journal:  Infect Drug Resist       Date:  2021-07-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.